Tag: blood_biomarkers
-
New NIH-Funded Model Improves Hypertrophic Cardiomyopathy Risk Prediction
NIH-funded research introduces an innovative model for hypertrophic cardiomyopathy risk assessment. By integrating clinical history, imaging, and blood biomarkers, the study significantly improves prediction of adverse cardiac events, potentially transforming patient management and outcomes.
HealthScience & TechnologyPolitics and GovernmentMedical ScienceFederal GovernmentEducationSocial Issues Hypertrophic CardiomyopathyRisk AssessmentNational Institutes of HealthCardiac MRIBlood BiomarkersHeart HealthMedical Research